171 related articles for article (PubMed ID: 30045987)
1. The HIV Integrase Inhibitor Raltegravir Inhibits Felid Alphaherpesvirus 1 Replication by Targeting both DNA Replication and Late Gene Expression.
Pennington MR; Voorhees IEH; Callaway HM; Dehghanpir SD; Baines JD; Parrish CR; Van de Walle GR
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045987
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome profiling of alphaherpesvirus-infected cells treated with the HIV-integrase inhibitor raltegravir reveals profound and specific alterations in host transcription.
Pennington MR; Grenier JK; Van de Walle GR
J Gen Virol; 2018 Aug; 99(8):1115-1128. PubMed ID: 29916804
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
Zhou B; Yang K; Wills E; Tang L; Baines JD
J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
[TBL] [Abstract][Full Text] [Related]
4. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
[TBL] [Abstract][Full Text] [Related]
5. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
[TBL] [Abstract][Full Text] [Related]
6. Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance.
Malet I; Thierry E; Wirden M; Lebourgeois S; Subra F; Katlama C; Deprez E; Calvez V; Marcelin AG; Delelis O
J Antimicrob Chemother; 2015 Oct; 70(10):2870-80. PubMed ID: 26205139
[TBL] [Abstract][Full Text] [Related]
7. Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex.
Ding J; Zhao J; Yang Z; Ma L; Mi Z; Wu Y; Guo J; Zhou J; Li X; Guo Y; Peng Z; Wei T; Yu H; Zhang L; Ge M; Cen S
Viruses; 2017 May; 9(5):. PubMed ID: 28489061
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
Wang Y; Mao L; Kankanala J; Wang Z; Geraghty RJ
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881652
[TBL] [Abstract][Full Text] [Related]
9. Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes.
Pollicita M; Surdo M; Di Santo F; Cortese MF; Fabeni L; Fedele V; Malet I; Marcelin AG; Calvez V; Ceccherini-Silberstein F; Perno CF; Svicher V
J Antimicrob Chemother; 2014 Sep; 69(9):2412-9. PubMed ID: 24860155
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Felid Herpesvirus-1 Deletion Mutants in Cats.
Lee Y; Maes RK; Kruger JM; Kiupel M; Giessler KS; Soboll Hussey G
Viruses; 2021 Jan; 13(2):. PubMed ID: 33499363
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Buzón MJ; Massanella M; Llibre JM; Esteve A; Dahl V; Puertas MC; Gatell JM; Domingo P; Paredes R; Sharkey M; Palmer S; Stevenson M; Clotet B; Blanco J; Martinez-Picado J
Nat Med; 2010 Apr; 16(4):460-5. PubMed ID: 20228817
[TBL] [Abstract][Full Text] [Related]
12. Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses.
Inoue N; Dambaugh TR; Rapp JC; Pellett PE
J Virol; 1994 Jul; 68(7):4126-36. PubMed ID: 8207791
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir.
Cattori V; Weibel B; Lutz H
Vet Microbiol; 2011 Aug; 152(1-2):165-8. PubMed ID: 21570781
[TBL] [Abstract][Full Text] [Related]
14. Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis.
Maes R
ISRN Vet Sci; 2012; 2012():495830. PubMed ID: 23762586
[TBL] [Abstract][Full Text] [Related]
15. [Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].
Delaugerre C
Med Mal Infect; 2010 Sep; 40 Suppl 1():S1-10. PubMed ID: 20800182
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of human immunodeficiency virus type 1 during virologic failure.
Fransen S; Karmochkine M; Huang W; Weiss L; Petropoulos CJ; Charpentier C
Antimicrob Agents Chemother; 2009 Oct; 53(10):4522-4. PubMed ID: 19667293
[TBL] [Abstract][Full Text] [Related]
17. A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1).
Pennington MR; Fort MW; Ledbetter EC; Van de Walle GR
J Gen Virol; 2016 Jun; 97(6):1414-1425. PubMed ID: 26959283
[TBL] [Abstract][Full Text] [Related]
18. Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs.
Thaljeh LF; Rothschild JA; Naderi M; Coghill LM; Brown JM; Brylinski M
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614784
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of human herpesviruses 6A and 6B.
Inoue N; Dambaugh TR; Pellett PE
Infect Agents Dis; 1993 Dec; 2(6):343-60. PubMed ID: 8012736
[TBL] [Abstract][Full Text] [Related]
20. A Mos1 transposase in vivo assay to screen new HIV-1 integrase inhibitors.
Cancian M; Loreto ELS
Genetica; 2018 Apr; 146(2):243-247. PubMed ID: 29352755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
